Literature DB >> 23298944

Current role of CT and whole body MRI in multiple myeloma.

R Duvauferrier1, M Valence2, S Patrat-Delon2, E Brillet3, E Niederberger3, A Marchand3, M Rescan3, R Guillin3, O Decaux2.   

Abstract

Radiology of bone lacunae can help differentiate between smouldering and symptomatic myeloma. CT seems to be more apt for this purpose than a standard X-ray but appropriate principles must be applied when performing and reading it. Lesions visible in an MRI above all allow myelomas to be monitored during treatment. Because of the radiation dose, whole body CT must be performed with a slice thickness of 2mm, increments of 1.5 and intensity of 40mAs. It should be read associating the reading of the axial slices with reading the mean coronal and sagittal projections of a thickness of 2cm. Whole body MRI must associate T1-weighted sagittal, STIR coronal and b-800 diffusion-weighted axial sequences. Changes in the disease correlate with changes in the diffusion, STIR and T1-weighted images interpreted together. While whole body CT has a place in clinical routine, the indication for whole body MRI still needs to be clarified and has yet to take its place in research protocols.
Copyright © 2012 Éditions françaises de radiologie. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23298944     DOI: 10.1016/j.diii.2012.12.001

Source DB:  PubMed          Journal:  Diagn Interv Imaging        ISSN: 2211-5684            Impact factor:   4.026


  4 in total

1.  Value of low-dose whole-body CT in the management of patients with multiple myeloma and precursor states.

Authors:  F Joseph Simeone; Joel P Harvey; Andrew J Yee; Elizabeth K O'Donnell; Noopur S Raje; Martin Torriani; Miriam A Bredella
Journal:  Skeletal Radiol       Date:  2018-09-14       Impact factor: 2.199

2.  The importance of bone marrow infiltration patterns in multiple myeloma seen on magnetic resonance imaging-Case report and imaging perspective.

Authors:  Dan Costachescu; Hortensia Ionita
Journal:  Clin Case Rep       Date:  2022-10-17

3.  Iterative decomposition of water and fat with echo asymmetry and least-squares estimation (IDEAL) magnetic resonance imaging as a biomarker for symptomatic multiple myeloma.

Authors:  Miyuki Takasu; Yoko Kaichi; Chihiro Tani; Shuji Date; Yuji Akiyama; Yoshiaki Kuroda; Akira Sakai; Kazuo Awai
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

4.  Role of whole-body MRI for treatment response assessment in multiple myeloma: comparison between clinical response and imaging response.

Authors:  Ho Young Park; Kyung Won Kim; Min A Yoon; Min Hee Lee; Eun Jin Chae; Jeong Hyun Lee; Hye Won Chung; Dok Hyun Yoon
Journal:  Cancer Imaging       Date:  2020-01-30       Impact factor: 3.909

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.